COVID-19 Vaccine-triggered Relapsing Immune Dysregulation: An Observational Study with Four-year Follow-up.

IF 3.1 Q4 NEUROSCIENCES
C S Vidhya Annapoorni, S R Chandra, Thomas Gregor Isaac
{"title":"COVID-19 Vaccine-triggered Relapsing Immune Dysregulation: An Observational Study with Four-year Follow-up.","authors":"C S Vidhya Annapoorni, S R Chandra, Thomas Gregor Isaac","doi":"10.1177/09727531261434290","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Vaccination against COVID-19 infection became mandatory because of the field situation during the pandemic.</p><p><strong>Purpose: </strong>Vaccine efficacy and safety need many field years of study; time constraints due to the pandemic limited the same. A hospital-based study was done in South India among patients who presented with immune-mediated disorders in temporal correlation with COVID-19 vaccination.</p><p><strong>Methods: </strong>The study period was 20 months, from March 2020 to November 2021. There were a total of 3,235 patients with neurological issues seen in two tertiary institutions, catering predominantly to patients from lower socio-economic strata in South India. A total of 1,007 (31.12%) patients had received COVID-19 vaccination (single dose in 511 [50.7%] and both doses in 496 [49.3%]). The general prevalence of primary demyelinating disease was compared with the background of vaccine-induced demyelination. Chi-square test was utilised for determining the association between neurological sequelae and the type of vaccine administered.</p><p><strong>Results: </strong>Eighteen patients had neurological sequelae, and 16 had a monophasic pattern. Recurrent autoimmunity was seen in two patients who took the Sputnik vaccine. Comparing the prevalence of primary multiple sclerosis (MS) versus vaccine-induced demyelination, there was a statistically significant difference (<i>χ</i> <sup>2</sup> = 572.38; <i>p</i> < .001), which indicates a definite role of vaccination in these patients. The association between neurological manifestations of Covishield and Covaxin showed no statistically significant difference in neurological sequelae (<i>χ</i> <sup>2</sup> = 0.0466; <i>p</i> = .8). The Sputnik vaccine was not considered, as the number was less than five. Anti-myelin oligodendrocyte glycoprotein-associated recurrent optic neuritis was seen in one patient, and tongue atrophy, pyramidal signs, ulcerative colitis and arthritis after 3 months, and C-ANCA positivity were seen following the Sputnik vaccine in one patient.</p><p><strong>Conclusion: </strong>Vaccination is an effective public health intervention. However, in susceptible individuals, it can probably trigger a recurrent and multisystem event by immune dysregulation. The association is an observation-based postulate that needs a longer, larger follow-up. As per this study, it is non-fatal and remits permanently.</p>","PeriodicalId":7921,"journal":{"name":"Annals of Neurosciences","volume":" ","pages":"09727531261434290"},"PeriodicalIF":3.1000,"publicationDate":"2026-06-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13314644/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annals of Neurosciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/09727531261434290","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"NEUROSCIENCES","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Vaccination against COVID-19 infection became mandatory because of the field situation during the pandemic.

Purpose: Vaccine efficacy and safety need many field years of study; time constraints due to the pandemic limited the same. A hospital-based study was done in South India among patients who presented with immune-mediated disorders in temporal correlation with COVID-19 vaccination.

Methods: The study period was 20 months, from March 2020 to November 2021. There were a total of 3,235 patients with neurological issues seen in two tertiary institutions, catering predominantly to patients from lower socio-economic strata in South India. A total of 1,007 (31.12%) patients had received COVID-19 vaccination (single dose in 511 [50.7%] and both doses in 496 [49.3%]). The general prevalence of primary demyelinating disease was compared with the background of vaccine-induced demyelination. Chi-square test was utilised for determining the association between neurological sequelae and the type of vaccine administered.

Results: Eighteen patients had neurological sequelae, and 16 had a monophasic pattern. Recurrent autoimmunity was seen in two patients who took the Sputnik vaccine. Comparing the prevalence of primary multiple sclerosis (MS) versus vaccine-induced demyelination, there was a statistically significant difference (χ 2 = 572.38; p < .001), which indicates a definite role of vaccination in these patients. The association between neurological manifestations of Covishield and Covaxin showed no statistically significant difference in neurological sequelae (χ 2 = 0.0466; p = .8). The Sputnik vaccine was not considered, as the number was less than five. Anti-myelin oligodendrocyte glycoprotein-associated recurrent optic neuritis was seen in one patient, and tongue atrophy, pyramidal signs, ulcerative colitis and arthritis after 3 months, and C-ANCA positivity were seen following the Sputnik vaccine in one patient.

Conclusion: Vaccination is an effective public health intervention. However, in susceptible individuals, it can probably trigger a recurrent and multisystem event by immune dysregulation. The association is an observation-based postulate that needs a longer, larger follow-up. As per this study, it is non-fatal and remits permanently.

COVID-19疫苗引发的复发性免疫失调:一项为期四年的随访观察性研究
背景:由于大流行期间的现场情况,预防COVID-19感染的疫苗接种成为强制性措施。目的:疫苗的有效性和安全性需要多年的实地研究;大流行造成的时间限制限制了这一点。在印度南部进行了一项基于医院的研究,研究对象是与COVID-19疫苗接种时间相关的免疫介导性疾病患者。方法:研究时间为20个月,从2020年3月至2021年11月。两所高等医疗机构共收治了3 235名患有神经系统疾病的患者,主要是印度南部社会经济阶层较低的患者。共有1007例(31.12%)患者接种了新冠肺炎疫苗,其中单剂511例(50.7%),双剂496例(49.3%)。将原发性脱髓鞘疾病的普遍患病率与疫苗诱导脱髓鞘的背景进行比较。卡方检验用于确定神经系统后遗症与接种疫苗类型之间的关系。结果:18例患者有神经系统后遗症,16例为单相。2例接种Sputnik疫苗的患者出现复发性自身免疫。原发性多发性硬化症(MS)患病率与疫苗诱导脱髓鞘患病率比较,差异有统计学意义(χ 2 = 572.38; p < .001),表明疫苗接种在这些患者中有明确的作用。Covishield与Covaxin在神经系统后遗症方面的相关性无统计学差异(χ 2 = 0.0466; p = 0.8)。没有考虑人造卫星疫苗,因为数量少于5个。1例患者出现抗髓鞘少突胶质细胞糖蛋白相关的复发性视神经炎,3个月后出现舌萎缩、锥体征、溃疡性结肠炎和关节炎,1例患者接种Sputnik疫苗后出现C-ANCA阳性。结论:预防接种是有效的公共卫生干预措施。然而,在易感个体中,它可能通过免疫失调引发复发性和多系统事件。这种关联是一种基于观察的假设,需要更长期、更大规模的随访。根据这项研究,它是非致命的,并且可以永久缓解。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Annals of Neurosciences
Annals of Neurosciences NEUROSCIENCES-
CiteScore
2.40
自引率
0.00%
发文量
39
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书